These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36925279)

  • 1. Conjugation site characterization of antibody-drug conjugates using electron-transfer/higher-energy collision dissociation (EThcD).
    Song Y; Gao J; Meng Q; Tang F; Wang Y; Zeng Y; Huang W; Shao H; Zhou H
    Anal Chim Acta; 2023 Apr; 1251():340978. PubMed ID: 36925279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signature Ions Triggered Electron-Transfer/Higher-Energy Collisional Dissociation (EThcD) for Specific and Confident Glycation Site Mapping in Therapeutic Proteins.
    Wang L; Nwosu C; Gao Y; Zhu MM
    J Am Soc Mass Spectrom; 2020 Mar; 31(3):473-478. PubMed ID: 32126780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Practical approaches for overcoming challenges in heightened characterization of antibody-drug conjugates with new methodologies and ultrahigh-resolution mass spectrometry.
    Friese OV; Smith JN; Brown PW; Rouse JC
    MAbs; 2018 Apr; 10(3):335-345. PubMed ID: 29393747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural Characterization of Daunomycin-Peptide Conjugates by Various Tandem Mass Spectrometric Techniques.
    Borbély A; Pethő L; Szabó I; Al-Majidi M; Steckel A; Nagy T; Kéki S; Kalló G; Csősz É; Mező G; Schlosser G
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug deconjugation-assisted peptide mapping by LC-MS/MS to identify conjugation sites and quantify site occupancy for antibody-drug conjugates.
    Wang T; Huang ZA; Zhou M; Wang R; Li Y; Guo L; Cao X; Huang J
    J Pharm Biomed Anal; 2024 Jun; 243():116098. PubMed ID: 38493753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive Middle-Down Mass Spectrometry Characterization of an Antibody-Drug Conjugate by Combined Ion Activation Methods.
    Watts E; Williams JD; Miesbauer LJ; Bruncko M; Brodbelt JS
    Anal Chem; 2020 Jul; 92(14):9790-9798. PubMed ID: 32567851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Middle-Down Multi-Attribute Analysis of Antibody-Drug Conjugates with Electron Transfer Dissociation.
    Chen B; Lin Z; Zhu Y; Jin Y; Larson E; Xu Q; Fu C; Zhang Z; Zhang Q; Pritts WA; Ge Y
    Anal Chem; 2019 Sep; 91(18):11661-11669. PubMed ID: 31442030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conjugation Site Analysis of Lysine-Conjugated ADCs.
    Sang H; Wan N; Lu G; Tian Y; Wang G; Ye H
    Methods Mol Biol; 2020; 2078():235-250. PubMed ID: 31643061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Case Study to Identify the Drug Conjugation Site of a Site-Specific Antibody-Drug-Conjugate Using Middle-Down Mass Spectrometry.
    Hernandez-Alba O; Houel S; Hessmann S; Erb S; Rabuka D; Huguet R; Josephs J; Beck A; Drake PM; Cianférani S
    J Am Soc Mass Spectrom; 2019 Nov; 30(11):2419-2429. PubMed ID: 31429052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Chemical Approaches for Site-Specific Conjugation of Native Antibodies: Technologies toward Next-Generation Antibody-Drug Conjugates.
    Yamada K; Ito Y
    Chembiochem; 2019 Nov; 20(21):2729-2737. PubMed ID: 30973187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural Characterization of a Monoclonal Antibody-Maytansinoid Immunoconjugate.
    Luo Q; Chung HH; Borths C; Janson M; Wen J; Joubert MK; Wypych J
    Anal Chem; 2016 Jan; 88(1):695-702. PubMed ID: 26629796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining Higher-Energy Collision Dissociation and Electron-Transfer/Higher-Energy Collision Dissociation Fragmentation in a Product-Dependent Manner Confidently Assigns Proteomewide ADP-Ribose Acceptor Sites.
    Bilan V; Leutert M; Nanni P; Panse C; Hottiger MO
    Anal Chem; 2017 Feb; 89(3):1523-1530. PubMed ID: 28035797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-Drug Conjugates (ADCs) Derived from Interchain Cysteine Cross-Linking Demonstrate Improved Homogeneity and Other Pharmacological Properties over Conventional Heterogeneous ADCs.
    Behrens CR; Ha EH; Chinn LL; Bowers S; Probst G; Fitch-Bruhns M; Monteon J; Valdiosera A; Bermudez A; Liao-Chan S; Wong T; Melnick J; Theunissen JW; Flory MR; Houser D; Venstrom K; Levashova Z; Sauer P; Migone TS; van der Horst EH; Halcomb RL; Jackson DY
    Mol Pharm; 2015 Nov; 12(11):3986-98. PubMed ID: 26393951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conjugation Site Analysis by MS/MS Protein Sequencing.
    Han L; Zhao Y; Zhang Q
    Methods Mol Biol; 2020; 2078():221-233. PubMed ID: 31643060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient HCD-pd-EThcD approach for N-glycan mapping of therapeutic antibodies at intact glycopeptide level.
    Li M; Zhu W; Zheng H; Zhang J
    Anal Chim Acta; 2022 Jan; 1189():339232. PubMed ID: 34815030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A hydrolyzed N-propionylthiosuccinimide linker is cleaved by metastable fragmentation, increasing reliability of conjugation site identification in conjugate vaccines.
    Ramos-Bermúdez PE; Pousa S; Carvalho P; Brant RSC; Batista M; Hojo H; Garay HE; Roscoe A; Mallón AR; Besada V; Takao T; González LJ
    Rapid Commun Mass Spectrom; 2024 Sep; 38(18):e9859. PubMed ID: 39034666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of ADCs by Native Mass Spectrometry.
    Hernandez-Alba O; Ehkirch A; Beck A; Cianférani S
    Methods Mol Biol; 2020; 2078():197-211. PubMed ID: 31643058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Novel Chemical Linkers for Next-generation Antibody-drug Conjugates(ADCs)].
    Tsuchikama K
    Yakugaku Zasshi; 2019; 139(2):209-219. PubMed ID: 30713230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GlycoHybridSeq: Automated Identification of N-Linked Glycopeptides Using Electron Transfer/High-Energy Collision Dissociation (EThcD).
    Zhang R; Zhu J; Lubman DM; Mechref Y; Tang H
    J Proteome Res; 2021 Jun; 20(6):3345-3352. PubMed ID: 34010560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal Dissociation Methods Differ for
    Riley NM; Malaker SA; Driessen MD; Bertozzi CR
    J Proteome Res; 2020 Aug; 19(8):3286-3301. PubMed ID: 32500713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.